Infections were more common in the daclizumab HYP group than in the interferon beta-@a group ( in @ % vs. @ % of the patients , including serious infection in @ % vs. @ % ) , as were cutaneous events such as rash or eczema ( in @ % vs. @ % , including serious events in @ % vs. < @ % ) and elevations in liver aminotransferase levels that were more than @ times the upper limit of the normal range ( in @ % vs. @ % ) .